David Turkaly
Stock Analyst at JMP Securities
(2.32)
# 1,409
Out of 4,479 analysts
94
Total ratings
41.07%
Success rate
-2.49%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintains: Market Outperform | $115 → $125 | $82.73 | +51.09% | 7 | May 10, 2024 | |
| STE STERIS | Reiterates: Market Outperform | $265 | $218.54 | +21.26% | 10 | May 9, 2024 | |
| FNA Paragon 28 | Maintains: Market Outperform | $23 → $20 | $6.58 | +203.95% | 4 | May 9, 2024 | |
| SIBN SI-BONE | Reiterates: Market Outperform | $32 | $12.90 | +148.06% | 5 | May 7, 2024 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $28.21 | +77.24% | 7 | May 7, 2024 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $49 → $40 | $28.97 | +38.07% | 11 | May 7, 2024 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $12.88 | - | 1 | Apr 22, 2024 | |
| TELA TELA Bio | Reiterates: Market Outperform | $15 | $4.49 | +234.08% | 4 | Mar 22, 2024 | |
| TFX Teleflex | Reiterates: Market Outperform | $285 | $211.44 | +34.79% | 10 | Feb 23, 2024 | |
| LNTH Lantheus Holdings | Reiterates: Market Outperform | $100 | $80.00 | +25.00% | 5 | Feb 23, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $160 → $140 | $105.96 | +32.13% | 10 | Nov 13, 2023 | |
| NVRO Nevro | Maintains: Outperform | $75 → $40 | $8.61 | +364.58% | 5 | Aug 2, 2023 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $67.92 | - | 1 | May 24, 2023 | |
| APYX Apyx Medical | Reiterates: Market Perform | n/a | $1.30 | - | 2 | May 24, 2023 | |
| STIM Neuronetics | Reiterates: Market Outperform | $12 | $1.75 | +585.71% | 4 | May 10, 2023 | |
| AXGN AxoGen | Reiterates: Market Outperform | $20 | $7.71 | +159.40% | 3 | May 10, 2023 | |
| ICAD iCAD, Inc. | Maintains: Outperform | $7 → $4 | $1.27 | +216.21% | 4 | Apr 13, 2023 | |
| CGNT Cognyte Software | Initiates: Outperform | n/a | $7.68 | - | 1 | Oct 6, 2017 |
Haemonetics
May 10, 2024
Maintains: Market Outperform
Price Target: $115 → $125
Current: $82.73
Upside: +51.09%
STERIS
May 9, 2024
Reiterates: Market Outperform
Price Target: $265
Current: $218.54
Upside: +21.26%
Paragon 28
May 9, 2024
Maintains: Market Outperform
Price Target: $23 → $20
Current: $6.58
Upside: +203.95%
SI-BONE
May 7, 2024
Reiterates: Market Outperform
Price Target: $32
Current: $12.90
Upside: +148.06%
OrthoPediatrics
May 7, 2024
Reiterates: Market Outperform
Price Target: $50
Current: $28.21
Upside: +77.24%
Integra LifeSciences Holdings
May 7, 2024
Maintains: Market Outperform
Price Target: $49 → $40
Current: $28.97
Upside: +38.07%
Orthofix Medical
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.88
Upside: -
TELA Bio
Mar 22, 2024
Reiterates: Market Outperform
Price Target: $15
Current: $4.49
Upside: +234.08%
Teleflex
Feb 23, 2024
Reiterates: Market Outperform
Price Target: $285
Current: $211.44
Upside: +34.79%
Lantheus Holdings
Feb 23, 2024
Reiterates: Market Outperform
Price Target: $100
Current: $80.00
Upside: +25.00%
Zimmer Biomet Holdings
Nov 13, 2023
Maintains: Market Outperform
Price Target: $160 → $140
Current: $105.96
Upside: +32.13%
Nevro
Aug 2, 2023
Maintains: Outperform
Price Target: $75 → $40
Current: $8.61
Upside: +364.58%
Globus Medical
May 24, 2023
Reiterates: Market Perform
Price Target: n/a
Current: $67.92
Upside: -
Apyx Medical
May 24, 2023
Reiterates: Market Perform
Price Target: n/a
Current: $1.30
Upside: -
Neuronetics
May 10, 2023
Reiterates: Market Outperform
Price Target: $12
Current: $1.75
Upside: +585.71%
AxoGen
May 10, 2023
Reiterates: Market Outperform
Price Target: $20
Current: $7.71
Upside: +159.40%
iCAD, Inc.
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $1.27
Upside: +216.21%
Cognyte Software
Oct 6, 2017
Initiates: Outperform
Price Target: n/a
Current: $7.68
Upside: -